✦ LIBER ✦

A new index of priority symptoms in advanced ovarian cancer

✍ Scribed by Sally E. Jensen; Sarah K. Rosenbloom; Jennifer L. Beaumont; Amy Abernethy; Paul B. Jacobsen; Karen Syrjala; David Cella

Book ID: 113962641
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 184 KB
Volume: 120
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2010.09.025

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Brief assessment of priority symptoms in

Brief assessment of priority symptoms in hormone refractory prostate cancer: The FACT Advanced Prostate Symptom Index (FAPSI)

✍ Susan Yount; David Cella; Donald Banik; Talat Ashraf; Daniel Shevrin 📂 Article 📅 2003 🏛 BioMed Central 🌐 English ⚖ 568 KB

Prognostic significance of DNA index in

Prognostic significance of DNA index in advanced ovarian cancer

✍ A. JAKOBSEN; P. BICHEL; I. STORNES 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB

Peritoneal cancer index: a prognostic in

Peritoneal cancer index: a prognostic indicator of survival in advanced ovarian cancer

✍ A.-A.K Tentes; G Tripsiannis; S.K Markakidis; C.N Karanikiotis; G Tzegas; G Geor 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Priority Symptoms in Advanced Breast Can

Priority Symptoms in Advanced Breast Cancer: Development and Initial Validation of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16)

✍ Sofia F. Garcia; Sarah K. Rosenbloom; Jennifer L. Beaumont; Douglas Merkel; Jami 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 380 KB

New approaches in radiotherapy for treat

New approaches in radiotherapy for treatment of advanced ovarian cancer

✍ William R. Redwood; Hubert A. Eddy; Omar M. Salazar 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Promising new therapies in the treatment

Promising new therapies in the treatment of advanced ovarian cancer

✍ Carolyn D. Runowicz; Abbie L Fields; Gary L. Goldberg 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 599 KB

Advanced stage ovarian cancer is the most lethal gynecologic cancer. Despite initial response rates of 60-80'/0 with platinum-based chemotherapy, more than 75% of women with this malignancy die of complications associated with this disease. There is a pressing need to find new chemotherapeutic agent